| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.037 | 0.8 |